Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease

计划入组 1,500 人 · 首次发布于 2014 年 1 月 20 日

The Long Term Outcome of Varus Derotational Osteotomy for Legg-Calvé-Perthes' Disease

计划入组 35 人 · 首次发布于 2016 年 2 月 8 日

Robotic Arm-assisted THA Vs. Conventional THA in Legg-Calvé-Perthes Disease

计划入组 50 人 · 首次发布于 2025 年 8 月 14 日

liver disease program

siRNA therapeutics for ocular disease/dermatological disease (Phio Pharmaceuticals)

undisclosed drug (fibrotic liver disease/NASH), Engitix/Takeda

Rare Disease Research, LLC

CASTLEMAN DISEASE COLLABORATIVE NETWORK

United States

CURE RARE DISEASE, INC.

United States

Medivir Raises SEK 130 Million to Advance MIV-711 as First Pharmacological Treatment for Pediatric Perthes Disease

Medivir Reports Q2 2026: Fostrox Phase 2 FLEX-HCC Underway, MIV-711 Expanded into Perthes Disease

StarkAge Therapeutics Partners with Gustave Roussy to Advance First-in-Class Senolytic ADC for Digestive Cancers